Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

P06-001: (EX)Amination of (P)NH, by (L)Evel (O)f CD59 on (RE)d and White Blood Cells, in Bone Marrow Failure Syndromes

NCT01192425 is registered in ClinicalTrials.gov with Alexion Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01192425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01192425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
P06-001: (EX)Amination of (P)NH, by (L)Evel (O)f CD59 on (RE)d and White Blood Cells, in Bone Marrow Failure Syndromes
Lead sponsor
Alexion Pharmaceuticals, Inc.
Phase
Observational
Overall status
Completed
Start date
September 1, 2010
Completion date
September 30, 2010
Enrollment
5,580 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemoglobinuria